» Articles » PMID: 32503496

The Gut Microbiota Profile of Adults with Kidney Disease and Kidney Stones: a Systematic Review of the Literature

Overview
Journal BMC Nephrol
Publisher Biomed Central
Specialty Nephrology
Date 2020 Jun 7
PMID 32503496
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There is mounting evidence that individuals with kidney disease and kidney stones have an abnormal gut microbiota composition. No studies to date have summarised the evidence to categorise how the gut microbiota profile of these individuals may differ from controls. Synthesis of this evidence is essential to inform future clinical trials. This systematic review aims to characterise differences of the gut microbial community in adults with kidney disease and kidney stones, as well as to describe the functional capacity of the gut microbiota and reporting of diet as a confounder in these studies.

Methods: Included studies were those that investigated the gut microbial community in adults with kidney disease or kidney stones and compared this to the profile of controls. Six scientific databases (CINHAL, Medline, PubMed, Scopus, Web of Science and Cochrane Library), as well as selected grey literature sources, were searched. Quality assessment was undertaken independently by three authors. The system of evidence level criteria was employed to quantitatively evaluate the alteration of microbiota by strictly considering the number, methodological quality and consistency of the findings. Additional findings relating to altered functions of the gut microbiota, dietary intakes and dietary methodologies used were qualitatively summarised.

Results: Twenty-five articles met the eligibility criteria and included data from a total of 892 adults with kidney disease or kidney stones and 1400 controls. Compared to controls, adults with kidney disease had increased abundances of several microbes including Enterobacteriaceae, Streptococcaceae, Streptococcus and decreased abundances of Prevotellaceae, Prevotella, Prevotella 9 and Roseburia among other taxa. Adults with kidney stones also had an altered microbial composition with variations to Bacteroides, Lachnospiraceae NK4A136 group, Ruminiclostridium 5 group, Dorea, Enterobacter, Christensenellaceae and its genus Christensenellaceae R7 group. Differences in the functional potential of the microbial community between controls and adults with kidney disease or kidney stones were also identified. Only three of the 25 articles presented dietary data, and of these studies, only two used a valid dietary assessment method.

Conclusions: The gut microbiota profile of adults with kidney disease and kidney stones differs from controls. Future study designs should include adequate reporting of important confounders such as dietary intake to assist with interpretation of findings.

Citing Articles

The mechanism of enterogenous toxin methylmalonic acid aggravating calcium-phosphorus metabolic disorder in uremic rats by regulating the Wnt/β-catenin pathway.

Fan X, Li J, Gao Y, Li L, Zhang H, Bi Z Mol Med. 2025; 31(1):19.

PMID: 39844078 PMC: 11756144. DOI: 10.1186/s10020-025-01067-y.


Gut microbiota and kidney function in autosomal dominant polycystic kidney disease participants in Cameroon: a cross-sectional study.

Obolo Nwaga I, Nzana V, Bughe R, Dah I, Cho-Fon C, Mahamat M BMC Nephrol. 2025; 26(1):20.

PMID: 39806306 PMC: 11727510. DOI: 10.1186/s12882-025-03942-6.


Inflammatory Bowel Diseases and Nephropathies: Exploring the Gut-Kidney Axis.

De Sire R, La Mantia A, Bonacci L, Testa A, Guarino A, Rispo A Life (Basel). 2025; 14(12.

PMID: 39768250 PMC: 11678131. DOI: 10.3390/life14121541.


Differences in microorganism profile in periprosthetic joint infections of the hip in patients affected by chronic kidney disease.

Stimolo D, Budin M, De Mauro D, Suero E, Gehrke T, Citak M J Orthop Traumatol. 2024; 25(1):67.

PMID: 39702802 PMC: 11659542. DOI: 10.1186/s10195-024-00806-x.


Effects of Composite Probiotic Food on Urinary, Serum Biochemical and Oxidative Stress Parameters in a Urolithiatic Rat Model.

Sreeja V, Suman D, Vahora N, Prajapati J Food Technol Biotechnol. 2024; 62(3):397-407.

PMID: 39497692 PMC: 11531678. DOI: 10.17113/ftb.62.03.24.8372.


References
1.
De Angelis M, Montemurno E, Piccolo M, Vannini L, Lauriero G, Maranzano V . Microbiota and metabolome associated with immunoglobulin A nephropathy (IgAN). PLoS One. 2014; 9(6):e99006. PMC: 4055632. DOI: 10.1371/journal.pone.0099006. View

2.
Roever L, Resende E, Diniz A, Penha-Silva N, OConnell J, Gomes P . Metabolic syndrome and risk of stroke: Protocol for an update systematic review and meta-analysis. Medicine (Baltimore). 2018; 97(15):e9862. PMC: 5908602. DOI: 10.1097/MD.0000000000009862. View

3.
Lun H, Yang W, Zhao S, Jiang M, Xu M, Liu F . Altered gut microbiota and microbial biomarkers associated with chronic kidney disease. Microbiologyopen. 2018; 8(4):e00678. PMC: 6460263. DOI: 10.1002/mbo3.678. View

4.
Allaband C, McDonald D, Vazquez-Baeza Y, Minich J, Tripathi A, Brenner D . Microbiome 101: Studying, Analyzing, and Interpreting Gut Microbiome Data for Clinicians. Clin Gastroenterol Hepatol. 2018; 17(2):218-230. PMC: 6391518. DOI: 10.1016/j.cgh.2018.09.017. View

5.
Nallu A, Sharma S, Ramezani A, Muralidharan J, Raj D . Gut microbiome in chronic kidney disease: challenges and opportunities. Transl Res. 2016; 179:24-37. PMC: 5086447. DOI: 10.1016/j.trsl.2016.04.007. View